【肝臟】首款超音波「肝臟」腫瘤消融組織反應預測AI「BioTrace」獲FDA De Novo許可

 【肝臟】首款超音波「肝臟」腫瘤消融組織反應預測AI「BioTrace」獲FDA De Novo許可

 文章出處  

PR Newswire 

 

 原文標題  

Techsomed's BioTrace Solution Achieves De Novo Clearance from FDA as the First Ultrasound-Based Software for Tissue Response Prediction in Liver Tumor Ablation 

 

 Twitter  

https://twitter.com/aimedadviser/status/1751885498027831517 

 

 文章序號  

5040 

 

智醫科學－AI醫療技術、應用與市場動態

Copyright ©2023 智醫科學 MEDai.tw All rights reserved.

The content of this site is intended for healthcare and medical professionals.